BusinessRafael Pharmaceuticals to Present New Data Validating Efficacy of CPI-613 in Treating Acute Myeloid Leukemia at the 2017 American Society of Hematology Annual Meeting & ExpositionBy Nasdaq OMXDec 7, 2017, 1:55 PM UTC
BusinessActinium Pharmaceuticals Highlights Strong Presence at 59th Annual American Society of Hematology Meeting Evidenced by Clinical Development Progress and Results Showcasing its AWE Technology PlatformBy Nasdaq OMXNov 29, 2017, 12:32 PM UTC
BusinessActinium Pharmaceuticals Announces Multiple Posters/Abstracts Accepted for 59th Annual American Society of Hematology Meeting Highlighting Company’s Drug Candidates and Technology PlatformBy Nasdaq OMXNov 1, 2017, 1:05 PM UTC
BusinessStemline Announces Four SL-401 Presentations at Upcoming ASH MeetingBy Nasdaq OMXNov 1, 2017, 1:02 PM UTC
BusinessImmuron Commences US Non-Deal Institutional Investor RoadshowBy Nasdaq OMXAug 15, 2017, 1:15 PM UTC
BusinessActinium Highlights Results from Phase 1 Clinical Trial of Actimab-A at 58th American Society of Hematology Annual MeetingBy Nasdaq OMXDec 6, 2016, 2:00 AM UTC
BusinessAkari Therapeutics Announces Corporate Update with New Positive Clinical Data and a New Pipeline of Tick Derived and Engineered ProteinsBy Nasdaq OMXDec 5, 2016, 12:00 PM UTC
BusinessFate Therapeutics Announces Oral Presentation on Natural Killer Cell Product Candidate FATE-NK100 at the 2016 ASH Annual MeetingBy Nasdaq OMXNov 3, 2016, 8:59 PM UTC
